<DOC>
	<DOCNO>NCT01602029</DOCNO>
	<brief_summary>Negative symptom cognitive deficit two partially-related feature schizophrenia major negative impact social function objective quality life . Standard drug treatment little impact either arguably effect primary negative symptom . Social dysfunction major economic consequence develop develop world . There evidence anti-inflammatory treatment may beneficial effect patient schizophrenia .</brief_summary>
	<brief_title>Randomized Double Blind Placebo Control Study Patients With Schizophrenia</brief_title>
	<detailed_description>Negative symptom cognitive deficit two partially-related feature schizophrenia major negative impact social function objective quality life . Evidence indicate anti-inflammatory treatment may beneficial effect schizophrenia . From preliminary randomise double-blind placebo-controlled clinical trial Pakistan Brazil , indicate addition minocycline ( antibiotic anti-inflammatory drug ) one year treatment usual ( TAU ) reduce negative symptom improve cognitive measure ( Chaudhry et al 2009 ) . Statins primarily HMG-CoA reductase inhibitor also anti-inflammatory agent know decrease C-reactive protein ( CRP ) . Higher level CRP ( &gt; 0.50 mg/dl ) associate marked negative symptom higher total PANSS score patient schizophrenia . ( Fan et al 2007 ) Ondansetron , selective 5-hydroxytryptamine-3 antagonist , quite commonly use antiemetic cancer patient ( Marty et al 1990 ) . There several small trial suggest ondansetron adjunct antipsychotic effective improve negative symptom memory patient suffer schizophrenia ( Ahkonzadeh et al 2009 , Levkovitz et al 2005 Zhang et al 2006 ) . The Primary objective study addition ondansetron /or simvastatin TAU patient schizophrenia result improvement negative symptom The Secondary objective include : - improvement positive symptom - social function - cognitive function - additive effect ondansetron simvastatin</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Inclusion Criteria 1 . Patients age 18 65 year 2 . Patients recruit inpatient outpatient . 3 . Diagnostic Statistical ManualIV ( DSMIV TR ) diagnosis schizophrenia , schizoaffective disorder , psychosis otherwise specify schizophreniform disorder 4 . Competent willing give inform consent 5 . Stable medication 4 week prior baseline 6 . No planned medication change 7 . Able take oral medication likely complete require evaluation 8 . Female participant child bear age must willing use adequate contraceptive duration study , , willing pregnancy test pre treatment ten weekly interval study medication , 9 . Not plan relocate next 12 month Exclusion Criteria 1 . Relevant ICD 10 organic brain disease neurological diagnosis ( include ECG conduction abnormality , neurological disorder , active seizure ) 2 . Subjects meet criterion DSMIV TR diagnosis alcohol substance abuse ( nicotine ) within last month criterion DSMIV TR alcohol substance dependence ( nicotine ) within last 6 month 3 . Any change psychotropic medication within previous 4 week 4 . Pregnant lactate woman reproductive age without adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Anti inflammatory</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Simvastatin</keyword>
	<keyword>Ondansetron</keyword>
</DOC>